2cureX AB (OSTO:2CUREX) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:2CUREX 2cureX AB OSTO:2CUREX
29 GF Score
Price kr1.87
! 3 Warning Signs
View Full Analysis

What is 2cureX AB FFO?

FFO (Funds from operations) only applies to REITs.

OSTO:2CUREX
29GF Score
2cureX AB OSTO:2CUREX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

2cureX AB Business Description

Other Exchanges 2QE:Germany
Address Fruebjergvej 3, Copenhagen, DNK, DK-2100
2cureX AB is a biotech company. The company is engaged in improving treatment efficiency, mainly for cancer patients. It is involved in developing a product, namely IndiTreat, which is a technology for the treatment of colorectal, ovarian, and pancreatic cancers. The company's sub-products include IndiTreat Test, IndiTreat clinical programs, and IndiTreat Therapy Design.
29GF Score

Get the complete analysis for OSTO:2CUREX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.87
Price